CTT Pharmaceutical Holdings Inc, (OTC: CTTH), a life sciences company with a portfolio of IP in novel drug delivery systems, announced yesterday that it has named Bob Allen as its new CFO and Marc Lakmaaker as strategic advisor.
Allen has acted as both CFO and CEO to large public corporations, including Ainsworth Lumber and the TimberWest Forest Corporation. He is an investor, entrepreneur and C-Suite executive with more than 20 years of experience in building, leading, and advising both public and private companies, including executing M&A and capital market transactions.
Lakmaaker is an executive with more than 20 years of capital markets, management and communications experience. He has knowledge of the cannabis industry, with a strong network of analysts, investors, influencers and industry participants. Lakmaaker is the founder of Clearview Capital Consult, a strategic and communications advisory focused on the cannabis, technology and industrial technology sectors. Prior to this, he was head of investor relations and director of Corporate Development at Aurora Cannabis. He will be working with management on the development and execution of corporate and capital markets strategies.
Zydus enters exclusive talks to acquire majority stake in Amplitude Surgical
Adcendo's ADCE-T02 Phase I study IND application receives US FDA approval
WHO grants Actinogen Medical's Xanamem/UE2343 non-proprietary name 'emestedastat'
IVFMD physicians named 2025 Castle Connolly Top Doctors
HOPE Therapeutics and NRx Pharmaceuticals select BTIG as financial advisor
Partillion Bioscience opens pre-orders for Nanovial Multicell Assay Antibody Discovery Kits
Champions Oncology expands bioanalytical services with new technology
Petauri's Nicole Lodowski named to MM+M's 40 Under 40 for 2025
WuXi XDC Cayman wins 'Best CDMO' at World ADC Awards 2024
Nektar Therapeutics agrees sale of Huntsville manufacturing facility and reagent supply business